Cory Sago

Cory Sago is the Chief Executive Officer and Founder of Amplitude Therapeutics, where activities are currently in stealth mode. Prior to this role, Cory served as Senior Director and Head of LNP Discovery at Beam Therapeutics, leading a team of over 20 to develop novel lipid nanoparticles for tissue delivery. As a co-founder and Chief Technology Officer of Guide Therapeutics, Cory contributed to advancing therapeutic solutions alongside Dr. James Dahlman. Academic experience includes a Doctor of Philosophy in Biomedical Engineering from Emory University and Georgia Institute of Technology, a Master's in Chemistry and Chemical Biology, and a Bachelor's in Biology from Rensselaer Polytechnic Institute. Early research involvement spans various laboratories, focusing on drug delivery, tissue engineering, and cancer research.